Norway· NO-ID_EC5884AC-6BF4-4BF5-B912-544CA8A2E45E
Ponvory
A ponesimod product containing ponesimod, registered in Norway by LABORATOIRES JUVISE PHARMACEUTICALS. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Ponesimod is registered in 11 of 19 countries.
Countries holding a registration under ATC L04AE04 (ponesimod), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Ponesimod · ATC L04AE04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ponesimod costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ponesimod · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- IT Italy$69.77
- CH Switzerland$69.06
The record
At a glance
FEST (Norway)- Active substance
- Ponesimod
- Manufacturer
- LABORATOIRES JUVISE PHARMACEUTICALS
- Country
- Norway (NO)
- ATC code
- L04AE04
- ATC class
- Ponesimod
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_EC5884AC-6BF4-4BF5-B912-544CA8A2E45E
- no_varenummer45370228NOK 19798.8
- gtin7323281005605
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ponesimod in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPONVORYLaboratoires Juvisé Pharmaceuticals, Villeurbanne
- United StatesPONVORYVanda Pharmaceuticals Inc.
- SpainPONVORY 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULALaboratoires Juvise Pharmaceuticals
- FinlandPonvoryLaboratoires Juvise Pharmaceuticals
- FrancePONVORY 20 mg, comprimé pelliculéLABORATOIRES JUVISE PHARMACEUTICALS
- BelgiumPonvory 20 mgLaboratoires Juvise Pharmaceuticals
- IcelandPonvoryLABORATOIRES JUVISE PHARMACEUTICALS
- NetherlandsPonvory 20 mg filmomhulde tablettenLaboratoires Juvise Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Ponvory
- Liechtenstein · Ponvory
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a291ab0d-a266-41f9-9dcf-6e9d53abc3e3 GET /v1/drugs/a291ab0d-a266-41f9-9dcf-6e9d53abc3e3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Ponesimod",
"merkevare_id": "ID_EC5884AC-6BF4-4BF5-B912-544CA8A2E45E",
"name_form_strength": "Ponvory tab 20 mg",
"prescription_group": "C"
}See everything about ponesimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.